The effects of interferon-γ on the central nervous system

Molecular Neurobiology

Volumn 14, Issue 1-2, 1997, Pages 19-35

  Popko, Brian ^a   Corbin, Joshua G ^a   Baerwald, Kristine D ^a   Dupree, Jeffrey ^a   Garcia, Annie M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Demyelination; Neural development

Indexed keywords

GAMMA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ASTROCYTE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INTERFERON TYPE II; MULTIPLE SCLEROSIS; NEURONS;

EID: 0031063399     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740619     Document Type: Article

References (147)

1. Agresti C., D'Urso D., and Levi G. (1996) Reversible inhibitory effects of interferon-γ and tumouar necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 8, 1106-1116.
2. Aguet M., Dembic Z., and Merlin G. (1988) Molecular cloning and expression of the human interferon-γ receptor. Cell 55, 273-280.
3. Alvord E. C. Jr., Kies M. W., and Suckling A. J. (1984) Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. Alan R. Liss, New York.
4. Bach E. A., Tanner J. W., Marsters S., Ashkenazi A., Aguet M., Shaw A. S., and Schreiber R. D. (1996) Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol. Cell. Biol. 16, 3214-3221.
5. Balasingam V., Tejada-Berges T., Wright E., Bouckova R., and Yong V. W. (1994) Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14, 846-856.
6. Barish M. E., Mansdorf N. B., and Raissdana S. S. (1991) Gamma-interferon promotes differentiation of cultured cortical and hippocampal neurons. Dev. Biol. 144, 412-423.
7. Beck J., Rondot L., Catinot L., Falcoff E., Kirchner H., and Wietzerbin J. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78, 318-323.
8. Benveniste E. N. (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Cell Physiol. 32, C1-C16.
9. Benveniste E. N. and Benos D. J. (1995) TNF-α and IFN-γ-mediated signal transduction pathways: effects on glial cell gene expression and function. FASEB J. 9, 1577-1584.
10. Bergsteinsdottir K., Brennan A., Jessen K. R., and Mirsky R. (1992) In the presence of dexamethasone, γ interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 89, 9054-9058.
11. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., and Carton H. (1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140, 1506-1510.
12. Birdsall H. H. (1991) Induction of ICAM-1 on human neural cells and mechanisms of neutrophil-mediated injury. Am. J. Pathol. 139, 1341-1350.
13. Birmingham M. K., Sar M., and Stumpf W. E. (1984) Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography. Neurochem. Res. 9, 333-350.
14. Bö L., Dawson T. M., Wesselingh S., Mörk S., Choi S., Kong P. A., Hanley D., and Trapp B. D. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol 36, 778-786.
15. Booss J., Esiri M. M., and Tourtellotte W. W. (1983) Immunohistochemical analysis of T-lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62, 19-32.
16. Brosnan C. F., Litwak M. S., Schroeder C. E., Selmaj K., Raine C. S., and Arezzo J. C. (1989) Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit. J. Neuroimmunol. 25, 227-239.
17. Calder V. L., Wolswijk G., and Noble M. (1988) The differentiation of 0-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. Eur. J. Immunol. 18, 1195-1201.
18. Chang J. Y., Martin D. P., and Johnson E. M. Jr. (1990) Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J. Neurochem. 55, 436-445.
19. Chuong C. M. (1990) Differential roles of multiple adhesion molecules in cell migration: granule cell migration in cerebellum. Experientia 46, 892-899.
20. Collins A. R. (1995) Interferon g potentiates human coronavirus OC43 infection of neuronal cells by modulation of HLA class I expression. Immunol. Invest. 24, 977-986.
21. Corbin J. G., Kelly D., Rath E. M., Baerwald K. D., Suzuki K., and Popko B. (1996) Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol. Cell. Neurosci. 7, 354-370.
22. Crone C. (1986) The blood-brain barrier; a modified tight epithelium, in The Blood-Brain Barrier in Health and Disease (Suckling A. J., Rumsby M. G., and Bradbury M. W. B., eds.), Ellis Horwood, UK, pp. 17-40.
23. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A., and Stewart T. A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1742.
24. Darnell J. E. Jr., Kerr I. M., and Stark G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
25. David M. (1995) Transcription factors in interferon signaling. Pharmacol. Ther. 65, 149-161.
26. Dighe A. S., Farrar M. A., and Schreiber R. D. (1993) Inhibition of cellular responsiveness to interferon-γ (IFNγ) induced by overexpression of inactive forms of the IFNγ receptor. J. Biol. Chem. 268, 10,645-10,653.
27. Dighe A. S., Campbell D., Hsieh C.-S., Clarke S., Greaves D. R., Gordon S., Murphy K. M., and Schreiber R. D. (1995) Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immunity 3, 657-666.
28. Duong T. T., St. Louis J., Gilbert J. J., Finkelman F. D., and Strejan G. H. (1992) Effect of anti-interferon-γ and anti-interleukin-w monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36, 105-115.
29. Duong T. T., Finkelman F. D., Singh B., and Strejan G. H. (1994) Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53, 101-107.
30. Ealick S. E., Cook W. J., Vijay-Kumar S., Carson M., Nagabhushan T. L., Trotta P. P., and Bugg C. E. (1991) Three-dimensional structure of recombinant human IFN-γ. Science 252, 698-702.
31. Eng, L. F. (1988). Regulation of glial intermediate filaments in astrogliosis, in The Biochemical Pathology of Astrocytes (Norenberg M. D., Hertz L., and Schousboe A., eds.), Liss, New York, pp. 79-90.
32. Erbe D. V., Collins J. E., Shen L., Graziano R. F., and Fanger M. W. (1990) The effect of cytokines on the expression and function of FC receptors for IgG on human myeloid cells. Mol. Immunol. 27, 57-67.
33. Fabry Z., Raine C. S., and Hart M. N. (1994) Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15, 219-224.
34. Farrar M. A. and Schreiber R. D. (1993) The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571-611.
35. Ferber I. A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., and Fathman C. G. (1996) Mice with a disrupted interferon-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7.
36. Ferm M. T., Soderstrom K., Jindal S., Gronberg A., Ivanyi J., Young R., and Kiessling R. (1992) Induction of human hsp60 expression in monocytic cell lines. Intl. Immunol. 4, 305-311.
37. Fierz W., Endler B., Reske K., Wekerle H., and Fontana A. (1985) Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 134, 3785-3793.
38. Fontana A., Fierz W., and Wekerle H. (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307, 273-276.
39. Fountoulakis M., Zulauf M., Lustig A., and Garotta G. (1992) Stoichiometry of interaction between interferon γ and its receptor. Eur. J. Biochem. 208, 781-787.
40. Frohman E. M., Frohman T. C., Dustin M. L., Vayuvegula B., Choi B., Gupta A., van den Noort S., and Gupta S. (1989) The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23, 117-124.
41. Gajewski T. F., Schell S. R., Nau G., and Fitch F. W. (1989) Regulation of T-cell activation: differences among T cell subsets. Immunol. Rev. 111, 79-110.
42. Gao Y. L., Brosnan C. F., and Raine C. S. (1995) Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J. Immunol. 154, 3548-3556.
43. Gray P. W. and Goeddel D. V. (1982) Structure of the human immune interferon gene. Nature 298, 859-863.
44. Gray P. W. and Goeddel D. V. (1983) Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 80, 5842-5846.
45. Gray P. W., Leung D. W., Pennica D., Yelverton E., Najarian R., Simonsen C. C., Derynck R., Sherwood P. J., Wallace D. M., Berger S. L., Levinson A. D., and Goeddel D. V. (1982) Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295, 503-508.
46. Greenlund A. C., Schreiber R. D., Goeddel D. V., and Pennica D. (1993) Interferon-γ induces receptor dimerization in solution and on cells. J. Biol. Chem. 268, 18,103-18,110.
47. Hartung H.-P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J. J., and Toyka K. V. (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40, 197-210.
48. Hayes C., Kelly D., Murayama S., Komiyama A., Suzuki K., and Popko B. (1992) Expression of the neu oncogene under the transcriprional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells. J. Neurosci. Res. 31, 175-187.
49. Hemmi S., Böhni R., Stark G., Di Marco F., and Aguet M. (1994) A novel member of the interferon receptor family complements functionality of the murine interferon γ receptor in human cells. Cell 76, 803-810.
50. Hickey W. F. (1991) Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1, 97-105.
51. Huynh H. K. and Dorovini-Zis Z. K. (1993) Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells. Am. J. Pathol. 142, 1265-1278.
52. Improta T., Salvatore A. M., Di Luzio A., Romeo G., Coccia E. M., and Calissano P. (1988) IFN-gamma facilitates NGF-induced neuronal differentiation in PC12 cells. Exp. Cell Res. 179, 1-9.
53. Jindal S. (1996) Heat shock proteins: applications in health and disease. Trends Biotechnol. 14, 17-20.
54. Joly E. and Oldstone M. B. (1992) Neuronal cells are deficient in loading peprides onto MHC class I molecules. Neuron 8, 1185-1190.
55. Joly W., Mucke L., and Oldstone M. B. (1991) Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253, 1283-1285.
56. Kelker H. C., Yip U. K., Anderson P., and Vilcek J. (1983) Effects of glycosidase treatment on the physicochemical properties and biological activity of human interferon-γ. J. Biol. Chem. 258, 8010-8013.
57. Koprowski H., Zheng Y. M., Heber-Katz E., Fraser N., Rorke L., Fu Z. F., Hanlon C., and Dietzschold B. (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90, 3024-3027.
58. Kumar S., Cole R., Chiapelli F., and de Vellis J. (1989) Differential regulation of oligodendrocyte markers by glucocorticoids: post-transcriptional regulation of both proteolipid protein and myelin basic protein and transcriptional regulation of glycerol phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 86, 6807-6811.
59. Li Y., Atashi J., Hayes C., Reap E., Hunt III D., and Popko B. (1995) Morphological and molecular response of the MOCH-1 oligodendrocyte cell line to serum and interferon-γ: possible implications for demyelinating disorders. J. Neurosci. Res. 40, 189-198.
60. Martin R. and McFarland H. F. (1995) Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32, 121-182.
61. Martin R., McFarland H. F., and McFarlin D. E. (1992) Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10, 153-187.
62. Massa P. T., Ozato K., and McFarlin D. E. (1993) Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8, 201-207.
63. Mauerhoff T., Pujol-Borrell R., Mirakian R., and Bottazzo G. F. (1988) Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human fetal brain. J. Neuroimmunol. 18, 271-289.
64. McMillian M., Kong L. Y., Sawin S. M., Wilson B., Das K., Hudson P., Hong J. S., and Bing G. (1995) Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem. Biophys. Res. Commun. 215, 572-577.
65. McCarron R. M., Wang L., Racke M. K., McFarlin D. E., and Spatz M. (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43, 23-30.
66. McRae B. L., Kennedy M. K., Tan L.-J., Dal Canto M. C., Picha K. S., and Miller S. D. (1992) Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38, 229-240.
67. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., and Rossi F. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647-650.
68. Merrill J. E., Ignarro L. J., Sherman M. P., Melinek J., and Lane T. E. (1993) Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
69. Miller S. D., McRae B. L., Vanderlugt C. L., Nikcevich K. M., Pope J. G., Pope L., and Karpus W. J. (1995) Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144, 225-244.
70. Mitrovic B., Ignarro L. J., Vinters H. V., Akers M. A., Schmid I., Uittenbogaart C., and Merrill J. E. (1995) Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65, 531-539.
71. Momburg F., Koch N., Moller P., Moldenhauer G., Butcher G. W., and Hammerling G. J. (1986) Differential expression of Ia and la-associated invariant chain in mouse tissue after in vivo treatment with IFN-γ. J. Immunol. 136, 940-948.
72. Morange M., Dubois M. F., Bensaude O., and Lebon P. (1986) Interferon pretreatment lowers the threshold for maximal heat-shock response in mouse cells. J. Cell. Physiol. 127, 417-422.
73. Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A. G., Barbieri G., Witthuhn B. A., Schindler C., et al. (1993) The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and - gamma signal transduction. Nature 366, 129-135.
74. Neumann H., Cavalie A., Jenne D. E., and Wekerle H. (1995) Induction of MHC class I genes in neurons. Science 269, 549-552.
75. Olsson T. (1992) Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 40, 211-218.
76. Olsson T., Zhi W. W., Höjeberg B., Kostulas V., Jian Y. P., Anderson G., Ekre H.-P., and Link H. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest. 86, 981-985.
77. Panitch H. S. (1992) Interferons in multiple sclerosis. Drugs 44, 946-962.
78. Panitch H. S., Hirsch R. L., Schindler J., and Johnson K. P. (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37, 1097-1102.
79. Paul W. E. and Seder R. A. (1994) Lymphocyte responses and cytokines. Cell 76, 241-251.
80. Popko B., Hayes C., Li Y., Kelly D., Murayama S., and Suzuki K. (1994) MOCH-1 cells: an oligodendrocyte cell line generated using a transgenic approach, in A Multidisciplinary Approach to Myelin Diseases (Salvati S., ed.), Plenum, New York, pp. 103-113.
81. Poser C. M. (1987) Trauma and multiple sclerosis. J. Neurol. 234, 155-159.
82. Poser C. M. (1993) The pathogenesis of multiple sclerosis. Additional considerations. J. Neurol. Sci. 115 (Suppl.), S3-S15.
83. Power C., Kong P.-A., and Trapp B. D. (1996) Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J. Neurosci. Res. 44, 165-173.
84. Prabhaker S., Kurien E., Gupta R. S., Zielinski S., and Freedman M. S. (1994) Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. Neurology 44, 1644-1648.
85. Pulver M., Carrel S., Mach J. P., and de Tribolet N. (1987) Cultured human fetal astrocytes can be induced by interferon-gamma to express HLA-DR. J. Neuroimmunol. 14, 123-133.
86. Raine C. S. (1994a) The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36, S61-S72.
87. Raine C. S. (1994b) Presidential address: multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol 53, 328-337.
88. Ransohoff R. M. and Benveniste E. N. (1996) Cytokines and the CNS. CRC, Boca Raton, FL.
89. Reiner S. L. and Seder R. A. (1995) T helper cell differentiation in immune response. Curr. Opinion Immunol. 7, 360-366.
90. Renno T., Lin J. Y., Piccirillo C., Antel J., and Owens T. (1994) Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49, 1-7.
91. Rodriguez M. and Scheithauer B. (1994) Ultrastructure of multiple sclerosis. Ultrastructural Pathol. 18, 3-13.
92. Rosenman S. J., Shrikant P., Dubb L., Benveniste E. N., and Ransohoff R. M. (1995) Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154, 1888-1899.
93. Rubio N. and de Felipe C. (1991) Demonstration of the presence of a specific interferon-γ receptor on murine astrocyte cell surface. J. Neuroimmunol. 35, 111-117.
94. Ryder E. F., Snyder E. Y., and Cepko C. L. (1990) Establishment and characterization of multi-potent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21, 356-375.
95. Sadowski H. B., Shuai K., Darnell J. E. Jr., and Gilman M. Z. (1993) A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261, 1739-1744.
96. Sakatsume M., Igarashi K.-I., Winestock K. D., Garotta G., Lamer A. C., and Finbloom D. S. (1995) The Jak kinases differentially associate with the α and β (accessory factor) chains of the interferon γ receptor to form a functional receptor unit capable of activating STAT transcription factors. J. Biol. Chem. 270, 17,528-17,534.
97. Satoh J., Kastrukoff L. F., and Kim S. U. (1991a) Cytokine-induced expression of intercellular adhesion molecule-1 (ICAM-1) in cultured human oligodendrocytes and astrocytes. J. Neuropathol. Exp. Neurol. 50, 215-226.
98. Satoh J., Kim S. U., Kastrukoff L. F., and Takei F. (1991b) Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J. Neurosci. Res. 29, 1-12.
99. Schindler C. (1995) Cytokine signal transduction. Receptor 5, 51-62.
100. Schreiber R. D. and Celada A. (1985) Molecular characterization of interferon gamma as a macrophage activating factor. Lymphokines 11, 87-118.
101. Seder R. A. and Paul W. E. (1994) Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12, 635-673.
102. Selmaj K., Raine C. S., Farooq M., Norton W. T., and Brosnan C. F. (1991) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529.
103. Selmaj K., Brosnan C. F., and Raine C. S. (1992) Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: Implications for multiple sclerosis. Neurology 42, 795-800.
104. Sethna M. P. and Lampson L. A. (1991) Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34, 121-132.
105. Shaw G. and Kamen R. (1986) A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659-667.
106. Shuai K. (1994) Interferon-activated signal transduction to the nucleus. Curr. Opinion Cell Biol. 6, 253-259.
107. Shuai K., Stark G. R., Kerr I. M., and Darnell J. E. Jr. (1993) A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261, 1744-1746.
108. Simmons R. D. and Willenborg D. O. (1990) Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100, 37-42.
109. Skias D. D., Kim D. K., Reder A. T., Antel J. P., Lancki D. W., and Fitch F. W. (1987) Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J. Immunol. 138, 3254-3258.
110. Snapper C. M. and Paul W. E. (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236, 944-947.
111. Soh J., Donnelly R. J., Kotenko S., Mariano T. M., Cook J. R., Wany N., Emanuel S., Schwartz B., Miki T., and Pestka S. (1994) Identification and sequence of an accessory factor required for activation of the human interferon γ receptor. Cell 76, 793-802.
112. Steffen B. J., Butcher E. C., and Engelhardt B. (1994) Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145, 189-201.
113. Steiniger B. and van der Meide P. H. (1988) Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon. J. Neuroimmunol. 19, 111-118.
114. Suzumura A., Silberberg D. H., and Lisak R. P. (1986) The expression of MHC antigens on oligodendrocytes: induction of polymorphic H-2 expression by lymphokines. J. Neuroimmunol. 11, 179-190.
115. Swain S. L., Bradley L. M., Croft M., Tonkonogy S., Atkins G., Weinberg A. D., Duncan D. D., Hedrick S. M., Dutton R. W., and Huston G. (1991) Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123, 115-144.
116. Tamura K., Shimizu K., Yamada M., Okamoto Y., Matsui Y., Park K.-C., Mabuchi E., Moriuchi S., and Mogami H. (1989) Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation. Cancer Res. 49, 5380-5384.
117. Tjuvajev J., Gansbacher B., Desai R., Beattie B., Kaplitt M., Matei C., Koutcher J., Gilboa E., and Blasberg R. (1995) RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma. Cancer Res. 55, 1902-1910.
118. Torres C., Aránguez I., and Rubio N. (1995) Expression of interferon-γ receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology 86, 250-255.
119. Traugott U. and Lebon P. (1988) Demonstration of α, β, and γ interferon in active chronic multiple sclerosis lesions. Ann. NY Acad. Sci. 540, 309-311.
120. Traugott U., Reinherz E. L., and Raine C. S. (1983) Multiple sclerosis: distribution of T-cell subsets within active chronic lesions. Science 219, 308-310.
121. Trinchieri G. and Perussia B. (1985) Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol. Today 6, 131.
122. Tuohy V. K., Sobel R. A., and Lees M. B. (1988a) Myelin proteolipid protein-induced experimental allergic encephalomyelitis. J. Immunol. 140, 1868-1873.
123. Tuohy V. K., Lu Z., Sobel R. A., Laursen R. A., and Lees M. B. (1988b) A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 141, 1126-1130.
124. Tuohy V. K., Lu Z., Sobel R. A., Laursen R. A., and Lees M. B. (1989) Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142, 1523-1527.
125. Tuohy V. K., Sobel R. A., Lu Z., Laursen R. A., and Lees M. B. (1992) Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39, 67-74.
126. Turnley A. M. and Morahan G. (1995) Dysmyelination in class I MHC transgenic mice. Microsci. Res. Tech. 32, 286-294.
127. Turnley A. M., Miller J. F. A. P., and Bartlett P. F. (1991a) Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-γ and TNF-α. Neurosci. Lett. 123, 45-48.
128. Turnley A. M., Morahan G., Okano H., Bernard O., Mikoshiba K., Allison J., Bartlett P. F., and Miller J. F. A. P. (1991b) Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (Lond.) 353, 566-568.
129. Utz U. and McFarland H. F. (1994) The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor. J. Neuropathol. Exp. Neurol. 53, 351-358.
130. van Noort J. M., van Sechel A. C., Bajramovic J. J., el Ouagmiri M., Polman C. H., Lassmann H., and Ravid R. (1995) The small heat-shock protein alpha B-crystalline as candidate autoantigen in multiple sclerosis. Nature 375, 739-740.
131. Vartanian T., Li Y., Zhao M., and Stefansson K. (1995) Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1, 732-743.
132. Vass K., Heininger K., Schafer B., Linington C., and Lassmann H. (1992) Interferon-γ potentiates antibody-mediated demyelination in vivo. Ann. Neurol. 32, 198-206.
133. Vilcek J., and Oliveira I. (1994) Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions. Int. Arch. Allergy Immunol. 104, 311-316.
134. Vilcek J., Gray P. W., Rinderknecht E., and Sevastopoulos C. G. (1985) Interferon gamma: a lymphokine for all seasons. Lymphokines 11, 1-32.
135. Voorthuis J. A. C., Uitdehaag B. M. J., de Groot C. J. A., Goede P. H., van der Meide P. H., and Dijkstra C. D. (1990) Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81, 183-188.
136. Voskuhl R. R., Martin R., Bergman C., Calal M., Ruddle N. H., and McFarland H. F. (1993) T helper 1 (TH1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15, 137-143.
137. Walter M. R., Windsor W. T., Nagabhushan T. L., Lundell D. J., Lunn C. A., Zauodny P. J., and Narula S. K. (1995) Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 376, 217,218.
138. Watling D., Guschin D., Müller M., Silvennoinen O., Witthuhn B. A., Quelle F. W., Rogers N. C., Schindler C., Stark G. R., Ihle J. N., et al. (1993) Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366, 166-170.
139. Wheelock E. F. (1965) Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149, 310,311.
140. Willenborg D. O., Fordham S. A., Cowden W. B., and Ramshaw I. A. (1995) Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41, 31-41.
141. Wong G. H., Bartlett P. F., Clark-Lewis I., Battye F., and Schrader J. W. (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310, 688-691.
142. Wong G. H., Bartlett P. F., Clark-Lewis I., McKimm-Breschkin J. L., and Schrader J. W. (1985) Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells. J. Neuroimmunol. 7, 255-278.
143. Yong V. W., Moumdjian R., Yong F. P., Ruijs T. C. G., Freedman M. S., Cashman N., and Antel J. P. (1991) γ-Interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc. Natl. Acad. Sci. USA 88, 7016-7020.
144. Yong V. W., Tejada-Berges T., Goodyer C. G., Antel J. P., and Yong F. P. (1992) Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia 6, 269-280.
145. Yoshioka T., Feigenbaum L., and Jay G. (1991) Transgenic mouse model for central nervous system demyelination. Mol. Cell. Biol. 11, 5479-5486.
146. Young H. A. and Hardy K. J. (1995) Role of interferon-γ in immune cell regulation. J. Leukocyte Biol. 58, 373-381.
147. Zamvil S. S. and Steinman L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621.